KR20070072610A - 경구분산형 약제학적 조성물 - Google Patents

경구분산형 약제학적 조성물 Download PDF

Info

Publication number
KR20070072610A
KR20070072610A KR1020077011688A KR20077011688A KR20070072610A KR 20070072610 A KR20070072610 A KR 20070072610A KR 1020077011688 A KR1020077011688 A KR 1020077011688A KR 20077011688 A KR20077011688 A KR 20077011688A KR 20070072610 A KR20070072610 A KR 20070072610A
Authority
KR
South Korea
Prior art keywords
calcium
pharmaceutical composition
composition according
orally
weight
Prior art date
Application number
KR1020077011688A
Other languages
English (en)
Korean (ko)
Inventor
페르난데즈 알바로 아세브론
로우사메 돌로레스 블란코
구에레로 칸디다 가스코
Original Assignee
이탈파마코 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이탈파마코 에스.에이. filed Critical 이탈파마코 에스.에이.
Publication of KR20070072610A publication Critical patent/KR20070072610A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020077011688A 2004-10-25 2005-10-24 경구분산형 약제학적 조성물 KR20070072610A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200402560A ES2255429B1 (es) 2004-10-25 2004-10-25 Composiciones farmaceuticas bucodispersables.
ESP200402560 2004-10-25

Publications (1)

Publication Number Publication Date
KR20070072610A true KR20070072610A (ko) 2007-07-04

Family

ID=36227498

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077011688A KR20070072610A (ko) 2004-10-25 2005-10-24 경구분산형 약제학적 조성물

Country Status (10)

Country Link
US (1) US20090041860A1 (ja)
EP (1) EP1837019B1 (ja)
JP (1) JP5090918B2 (ja)
KR (1) KR20070072610A (ja)
DK (1) DK1837019T3 (ja)
ES (2) ES2255429B1 (ja)
PL (1) PL1837019T3 (ja)
PT (1) PT1837019E (ja)
RU (1) RU2405541C2 (ja)
WO (1) WO2006045870A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
BRPI0817927A2 (pt) * 2007-10-01 2015-04-07 Lesvi Laboratorios Sl Comprimidos orodispersiveis
JP5490691B2 (ja) * 2008-06-12 2014-05-14 株式会社三和化学研究所 炭酸カルシウム含有速崩壊性製剤
TR200900878A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
JP4562797B1 (ja) * 2009-05-29 2010-10-13 マイラン製薬株式会社 沈降炭酸カルシウムを有効成分とする口腔内崩壊錠
TR200908237A2 (tr) * 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
DE102010043318A1 (de) * 2010-11-03 2012-05-03 Klaus F. Kopp Calciumcarbonat enthaltende Zusammensetzung
CN102160648B (zh) * 2011-03-11 2012-06-27 陕西科技大学 一种口腔速崩钙片及其制备方法
WO2014076194A1 (en) * 2012-11-16 2014-05-22 Arcoral Pharma As Effervescent tablet
WO2015020191A1 (ja) * 2013-08-09 2015-02-12 日東薬品工業株式会社 カルシウム剤
KR20180062063A (ko) * 2016-11-30 2018-06-08 (주) 메티메디제약 서방형 항암용 약학 조성물
WO2019004984A2 (en) * 2017-05-29 2019-01-03 Biofarma Ilac Sanayi Ve Ticaret A.S. PHARMACEUTICAL FORMULATION COMPRISING CHOLECALCIFEROL
IT201700099708A1 (it) * 2017-09-06 2019-03-06 Abiogen Pharma Spa Composizione per l’integrazione di calcio
ES2945809T3 (es) 2019-10-02 2023-07-07 Intas Pharmaceuticals Ltd Composiciones farmacéuticas sólidas efervescentes prácticamente sin sodio

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965162A (en) * 1993-09-10 1999-10-12 Fuisz Technologies Ltd. Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom
US6716454B2 (en) * 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
AR014133A1 (es) * 1997-12-19 2001-02-07 Smithkline Beecham Corp Procedimiento para fabricar tabletas de dispersion rapida para administracion oral y una formulacion de dichas tabletas
ES2192136B1 (es) * 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.

Also Published As

Publication number Publication date
EP1837019A1 (en) 2007-09-26
ES2255429B1 (es) 2007-08-16
PT1837019E (pt) 2012-11-23
JP2008517981A (ja) 2008-05-29
DK1837019T3 (da) 2012-11-12
ES2255429A1 (es) 2006-06-16
RU2007116432A (ru) 2008-11-27
US20090041860A1 (en) 2009-02-12
JP5090918B2 (ja) 2012-12-05
ES2394456T3 (es) 2013-01-31
RU2405541C2 (ru) 2010-12-10
WO2006045870A1 (es) 2006-05-04
PL1837019T3 (pl) 2013-02-28
EP1837019B1 (en) 2012-08-29

Similar Documents

Publication Publication Date Title
KR20070072610A (ko) 경구분산형 약제학적 조성물
KR100898970B1 (ko) 칼슘-함유 화합물 및 당알코올을 포함하는 입상체
EP1768748B2 (en) Compositions comprising strontium and vitamin d and uses thereof
KR100893847B1 (ko) 칼슘-함유 화합물을 활성 물질로서 함유하는 씹어먹거나흡입 및 삼킬 수 있는 태블릿
EP1845949B1 (en) Melt granulation of a composition containing a calcium-containing compound
PT1660104E (pt) Formulação farmacêutica compreendendo compostos de lantânio
US6716454B2 (en) Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
PL181340B1 (pl) tabletki do gryzienia oraz sposób wytwarzania kompozycji terapeutycznejwitaminowo-wapniowej w jednolitej galenowej formie tabletki do gryzienia PL PL PL PL PL PL PL
TW200819135A (en) Composition without metallic taste
JPH01151515A (ja) 骨粗鬆症および関連障害の治療法
JP5168712B2 (ja) ナテグリニド含有製剤
EP1651191B1 (en) Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use
JP2001010977A (ja) 経口用組成物
HU211084B (en) Process for producing oral pharmaceutical composition of bone strengthening activity
JP2006508998A (ja) 悪性腫瘍に破壊的効果を有する薬剤及び該薬剤を製造する方法
RU2796676C1 (ru) Водорастворимые таблетки колекальциферола и способ их получения
UA79567C2 (en) Orodispersible pharmaceutical composition of antithrombolic compound
KR20200083971A (ko) 칼슘 보충용 조성물

Legal Events

Date Code Title Description
AMND Amendment
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
AMND Amendment
N231 Notification of change of applicant
B601 Maintenance of original decision after re-examination before a trial
J122 Written withdrawal of action (patent court)